A specific layoff date has not been disclosed.
Based on news reporting.
Gilead Sciences, Inc. is set to lay off nearly 200 workers as a result of its acquisition of Arcellx. The layoffs are part of the company's restructuring efforts following the completion of the acquisition. While specific details regarding the affected locations or departments were not disclosed, the decision reflects Gilead's strategic adjustments in response to the new operational landscape post-acquisition. The layoffs are anticipated to occur after the acquisition closes, although an exact date has not been provided. This move underscores Gilead's ongoing efforts to streamline its workforce in alignment with its business objectives.
Gilead Sciences, Inc. cut 200 jobs.
That is roughly 1.1% of the 18,000 people Gilead Sciences, Inc. employs.
LayoffTalk has tracked 16 layoff events at Gilead Sciences, Inc. since October 2023, affecting a combined 1,581 employees.
Anonymous by default. Be kind — people reading this may be going through it right now.
No comments yet. Be the first to share your thoughts.
Estimated figure based on news reporting. Not yet confirmed by Gilead Sciences, Inc..
Share your story anonymously — it helps others reading this feel less alone.
Share your story →Recent tracked events at this company.